Current view and perspectives in amyotrophic lateral sclerosis.

Area of Science:

• Neuroscience
• Neurology
• Motor Neuron Diseases

Background:

• Amyotrophic lateral sclerosis (ALS) is a progressive, fatal neurodegenerative disorder impacting motor neurons in the central nervous system.
• Patient survival in ALS is influenced by factors including clinical presentation, age, gender, respiratory function, weight, and Riluzole treatment.
• Currently, no cure for ALS exists, making palliative and symptomatic care crucial for patient management.

Purpose of the Study:

• To review recent advancements in understanding ALS pathophysiology.
• To highlight promising therapeutic strategies and potential biomarkers for ALS.
• To provide an overview of the current state of ALS research and future directions.

Main Methods:

• Literature review of recent scientific publications on ALS.
• Analysis of emerging therapeutic targets and mechanisms.
• Identification and evaluation of novel biomarkers for ALS.

Main Results:

• Growing scientific understanding of ALS motor neuron degeneration.
• Identification of multiple therapeutic targets, including those related to excitotoxicity, neuroinflammation, mitochondrial dysfunction, oxidative stress, and RNA metabolism.
• Emphasis on the critical need for reliable biomarkers in ALS research and clinical trials.

Conclusions:

• Despite the lack of a cure, significant progress is being made in ALS research.
• New therapeutic avenues targeting various pathological mechanisms show promise for future treatments.
• Biomarker discovery is essential for advancing therapeutic development and improving study designs in ALS.